Skip to Main Content
TABLE 1.

Baseline Characteristics

Glargine Group (n = 1,659)Detemir Group (n = 1,659)P
Age, years* 64 ± 14.7 63 ± 14.3 0.019 
Male sex, n (%) 774 (46.7) 779 (47.0) 0.862 
Race, n (%)
 African American
 Asian
 Caucasian
 Other 
870 (52.4)
4 (0.2)
649 (39.1)
136 (8.2) 
852 (51.4)
9 (0.5)
691 (41.7)
107 (6.4) 
0.076 
BMI, kg/m2* 31.2 ± 11.2 31.7 ± 12.2 0.214 
Baseline SCr, mg/dL* 1.4 ± 1.4 1.5 ± 1.7 0.081 
A1C, %* 8.5 ± 2.3 8.6 ± 2.2 0.326 
Initial blood glucose, mg/dL* 213.0 ± 93.2 211.1 ± 91.7 0.555 
Bacteremia, n (%) 10 (0.6) 51 (3.1) <0.001 
Insulin scale, n (%)
 High intensity
 Medium intensity
 Low intensity
 ICU
 Custom 
292 (17.6)
747 (45.0)
418 (25.2)
10 (0.6)
221 (13.3) 
357 (21.5)
1101 (66.4)
529 (31.9)
19 (1.1)
121 (7.3) 
0.004
<0.001
<0.001
0.093
<0.001 
Beta-blocker, n (%) 968 (58.3) 1122 (67.6) <0.001 
Steroid, n (%) 263 (15.9) 324 (19.5) 0.006 
Glargine Group (n = 1,659)Detemir Group (n = 1,659)P
Age, years* 64 ± 14.7 63 ± 14.3 0.019 
Male sex, n (%) 774 (46.7) 779 (47.0) 0.862 
Race, n (%)
 African American
 Asian
 Caucasian
 Other 
870 (52.4)
4 (0.2)
649 (39.1)
136 (8.2) 
852 (51.4)
9 (0.5)
691 (41.7)
107 (6.4) 
0.076 
BMI, kg/m2* 31.2 ± 11.2 31.7 ± 12.2 0.214 
Baseline SCr, mg/dL* 1.4 ± 1.4 1.5 ± 1.7 0.081 
A1C, %* 8.5 ± 2.3 8.6 ± 2.2 0.326 
Initial blood glucose, mg/dL* 213.0 ± 93.2 211.1 ± 91.7 0.555 
Bacteremia, n (%) 10 (0.6) 51 (3.1) <0.001 
Insulin scale, n (%)
 High intensity
 Medium intensity
 Low intensity
 ICU
 Custom 
292 (17.6)
747 (45.0)
418 (25.2)
10 (0.6)
221 (13.3) 
357 (21.5)
1101 (66.4)
529 (31.9)
19 (1.1)
121 (7.3) 
0.004
<0.001
<0.001
0.093
<0.001 
Beta-blocker, n (%) 968 (58.3) 1122 (67.6) <0.001 
Steroid, n (%) 263 (15.9) 324 (19.5) 0.006 
*

Mean ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal